TR201716207A2 - Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. - Google Patents
Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. Download PDFInfo
- Publication number
- TR201716207A2 TR201716207A2 TR2017/16207A TR201716207A TR201716207A2 TR 201716207 A2 TR201716207 A2 TR 201716207A2 TR 2017/16207 A TR2017/16207 A TR 2017/16207A TR 201716207 A TR201716207 A TR 201716207A TR 201716207 A2 TR201716207 A2 TR 201716207A2
- Authority
- TR
- Turkey
- Prior art keywords
- umeclidinium
- vilanterol
- pharmaceutical formulations
- formulations containing
- dry powder
- Prior art date
Links
- FVTWTVQXNAJTQP-UHFFFAOYSA-N diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Chemical compound C=1C=CC=CC=1C(C12CC[N+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 FVTWTVQXNAJTQP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004258 umeclidinium Drugs 0.000 title abstract 2
- DAFYYTQWSAWIGS-DEOSSOPVSA-N vilanterol Chemical compound C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 DAFYYTQWSAWIGS-DEOSSOPVSA-N 0.000 title abstract 2
- 229960004026 vilanterol Drugs 0.000 title abstract 2
- 239000000843 powder Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, Vilanterol ve Umeklidinyumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16238A TR201716238A1 (tr) | 2017-10-18 | 2017-10-20 | Yeni farmasötik bileşimler. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (tr) | 2017-10-20 | 2017-10-20 | Yeni umeklidinyum formülasyonları. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716207A2 true TR201716207A2 (tr) | 2019-05-21 |
Family
ID=67954794
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (tr) | 2017-09-30 | 2017-10-20 | Yeni umeklidinyum formülasyonları. |
| TR2017/16207A TR201716207A2 (tr) | 2017-10-18 | 2017-10-20 | Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. |
| TR2017/16209A TR201716209A2 (tr) | 2017-09-30 | 2017-10-20 | Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (tr) | 2017-09-30 | 2017-10-20 | Yeni umeklidinyum formülasyonları. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16209A TR201716209A2 (tr) | 2017-09-30 | 2017-10-20 | Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler. |
Country Status (1)
| Country | Link |
|---|---|
| TR (3) | TR201716203A1 (tr) |
-
2017
- 2017-10-20 TR TR2017/16203A patent/TR201716203A1/tr unknown
- 2017-10-20 TR TR2017/16207A patent/TR201716207A2/tr unknown
- 2017-10-20 TR TR2017/16209A patent/TR201716209A2/tr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201716203A1 (tr) | 2019-05-21 |
| TR201716209A2 (tr) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125595T1 (el) | Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης | |
| HUE061174T2 (hu) | 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény | |
| MX378273B (es) | Compuestos activos hacia bromodominios. | |
| DOP2017000306A (es) | Formulaciones farmacéuticas que contienen tenofovir y emtricitabina | |
| MX388733B (es) | Polvos secos antifungicos. | |
| IL283539A (en) | 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| MX389178B (es) | Formulacion de proporcion fija de insulina glargina/lixisenatida. | |
| DK3429559T3 (da) | Velsmagende sammensætninger indeholdende natriumphenylbutyrat og anvendelser deraf | |
| HUE057871T2 (hu) | Gyógyászati hatóanyagokat tartalmazó hialuronán konjugátumok, eljárások és kompozíciók | |
| IL313924A (en) | Pharmaceutical dry powder inhalation formulation | |
| CO2018014217A2 (es) | Composiciones farmacéuticas que comprenden safinamida | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| MX393915B (es) | Nuevas formulaciones orales de belinostat. | |
| MX2018009948A (es) | Formulaciones de oritavancina. | |
| EP3623384A4 (en) | ANTI-CLDN-5 ANTIBODY AND ACTIVE SUBSTANCE WITH THIS ANTIBODY | |
| EA201891848A1 (ru) | Фармацевтическая композиция для применения в лечении фиброза | |
| LT3097921T (lt) | Kompozicijos, apimančios geraniolį ir sausą imbierą, skirtos naudoti dirgliosios žarnos sindromo gydymui | |
| TR201714725A1 (tr) | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu | |
| TR201714728A1 (tr) | Beta-2 Agonist ve Kortikosteroid içeren kuru toz formülasyonu. | |
| CO2020006552A2 (es) | Composiciones farmaceuticas que comprenden safinamida | |
| TR201714893A1 (tr) | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. | |
| LV15003A (lv) | Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei | |
| EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| TR201716155A1 (tr) | Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. |